Encompass Health Co. (NYSE:EHC) Shares Acquired by Systematic Financial Management LP

Systematic Financial Management LP increased its position in Encompass Health Co. (NYSE:EHC - Free Report) by 0.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 464,295 shares of the company's stock after acquiring an additional 3,006 shares during the period. Encompass Health makes up about 1.1% of Systematic Financial Management LP's portfolio, making the stock its 18th biggest holding. Systematic Financial Management LP owned about 0.46% of Encompass Health worth $42,878,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after buying an additional 137 shares during the last quarter. Colonial Trust Co SC purchased a new stake in Encompass Health in the 4th quarter worth approximately $29,000. Transce3nd LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC increased its holdings in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares in the last quarter. Finally, Tompkins Financial Corp purchased a new stake in Encompass Health during the fourth quarter worth $46,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Buying and Selling

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the sale, the insider now owns 11,958 shares of the company's stock, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Mark J. Tarr sold 118,384 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the transaction, the chief executive officer now owns 527,070 shares of the company's stock, valued at $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 132,663 shares of company stock worth $16,034,082. 2.00% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. UBS Group upped their price objective on shares of Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Barclays lifted their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research note on Friday, April 25th. Truist Financial reissued a "buy" rating and issued a $135.00 price objective (up from $116.00) on shares of Encompass Health in a report on Monday, April 28th. KeyCorp boosted their price objective on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. Finally, William Blair reiterated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Nine research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $120.86.

Encompass Health Price Performance

Shares of EHC traded up $0.49 during trading hours on Tuesday, hitting $121.67. 751,820 shares of the stock were exchanged, compared to its average volume of 695,950. The stock's 50-day moving average price is $105.97 and its two-hundred day moving average price is $100.90. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The company has a market cap of $12.26 billion, a price-to-earnings ratio of 27.28, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. Encompass Health Co. has a 12-month low of $82.74 and a 12-month high of $121.98.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The company's quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the business earned $1.12 earnings per share. Research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.56%. Encompass Health's dividend payout ratio is presently 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.